- Home
- BILL vs TFX Comparison
BILL vs TFX Comparison
Compare BILL & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BILL
- TFX
- Stock Information
- Founded
- BILL 2006
- TFX 1943
- Country
- BILL United States
- TFX United States
- Employees
- BILL N/A
- TFX N/A
- Industry
- BILL EDP Services
- TFX Medical/Dental Instruments
- Sector
- BILL Technology
- TFX Health Care
- Exchange
- BILL Nasdaq
- TFX Nasdaq
- Market Cap
- BILL 4.7B
- TFX 5.1B
- IPO Year
- BILL 2019
- TFX N/A
- Fundamental
- Price
- BILL $51.08
- TFX $130.32
- Analyst Decision
- BILL Buy
- TFX Hold
- Analyst Count
- BILL 22
- TFX 9
- Target Price
- BILL $61.33
- TFX $141.57
- AVG Volume (30 Days)
- BILL 5.2M
- TFX 566.9K
- Earning Date
- BILL 11-06-2025
- TFX 10-30-2025
- Dividend Yield
- BILL N/A
- TFX 1.04%
- EPS Growth
- BILL N/A
- TFX N/A
- EPS
- BILL N/A
- TFX 4.18
- Revenue
- BILL $1,462,570,000.00
- TFX $3,041,342,000.00
- Revenue This Year
- BILL $13.50
- TFX $10.16
- Revenue Next Year
- BILL $16.99
- TFX $10.10
- P/E Ratio
- BILL N/A
- TFX $31.37
- Revenue Growth
- BILL 13.36
- TFX 1.11
- 52 Week Low
- BILL $36.55
- TFX $108.90
- 52 Week High
- BILL $100.19
- TFX $249.91
- Technical
- Relative Strength Index (RSI)
- BILL 62.79
- TFX 60.05
- Support Level
- BILL $45.46
- TFX $128.32
- Resistance Level
- BILL $54.97
- TFX $133.18
- Average True Range (ATR)
- BILL 2.28
- TFX 2.62
- MACD
- BILL 0.83
- TFX 0.12
- Stochastic Oscillator
- BILL 73.26
- TFX 69.51
About BILL BILL Holdings Inc.
BILL Holdings Inc is a provider of software-as-a-service, cloud-based payments and spend and expense management products, which allow users to automate accounts payable and accounts receivable transactions, enable businesses to easily connect with their suppliers or customers to do business, eliminate expense reports, manage cash flows and improve back office efficiency. Initial Public Offering and Follow-on Offering.
About TFX Teleflex Incorporated
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.